BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2379-2390

  Hu, Fen ^a,b   Meng, Xiangzhi ^a   Tong, Qi ^a   Liang, Lin ^a   Xiang, Rong ^a   Zhu, Tianhui ^a   Yang, Shuang ^a  

^a NANKAI UNIVERSITY   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 6; Breast cancer; Cell proliferation; MicroRNA 192; Retinoblastoma 1

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CYCLINE; MICRORNA 192; RETINOBLASTOMA 1 PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 84885895325     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.08.011     Document Type: Article

References (51)

1. Sherr C.J. Mammalian G1 cyclins. Cell 1993, 73:1059-1065.
2. Stull M.A., Rowzee A.M., Loladze A.V., Wood T.L. Growth factor regulation of cell cycle progression in mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 2004, 9:15-26.
3. Wozney J.M. Bone morphogenetic proteins. Prog. Growth Factor Res. 1989, 1:267-280.
4. Celeste A.J., Iannazzi J.A., Taylor R.C., Hewick R.M., Rosen V., Wang E.A., Wozney J.M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9843-9847.
5. Clement J.H., Sänger J., Höffken K. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int. J. Cancer 1999, 80:250-256.
6. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000, 57:2207-2214.
7. Vukicevic S., Grgurevic L. BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev. 2009, 20:441-448.
8. Visser R., Arrabal P.M., Santos-Ruiz L., Becerra J., Cifuentes M. Basic fibroblast growth factor enhances the osteogenic differentiation induced by bone morphogenetic protein-6 in vitro and in vivo. Cytokine 2012, 58:27-33.
9. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 1992, 32:160-167.
10. Gitelman S.E., Kobrin M.S., Ye J.Q., Lopez A.R., Lee A., Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J. Cell Biol. 1994, 126:1595-1609.
11. Friedman M.S., Long M.W., Hankenson K.D. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell. Biochem. 2006, 98:538-554.
12. Mizrahi O., Sheyn D., Tawackoli W., Kallai I., Oh A., Su S., Da X., Zarrini P., Cook-Wiens G., Gazit D., Gazit Z. BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells. Gene Ther. 2013, 20:370-377.
13. Ong D.B., Colley S.M., Norman M.R., Kitazawa S., Tobias J.H. Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha. J. Bone Miner. Res. 2004, 19:447-454.
14. Yang S., Du J., Wang Z., Yuan W., Qiao Y., Zhang M., Zhang J., Gao S., Yin J., Sun B., Zhu T. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer 2007, 7:211.
15. Zhang M., Wang Q., Yuan W., Yang S., Wang X., Yan J.D., Du J., Yin J., Gao S.Y., Sun B.C., Zhu T.H. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 2007, 105:91-97.
16. Du J., Yang S., An D., Hu F., Yuan W., Zhai C., Zhu T. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Res. 2009, 19:487-496.
17. Yang S., Du J., Wang Z., Yan J., Yuan W., Zhang J., Zhu T. Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer. Int. J. Biochem. Cell Biol. 2009, 41:853-861.
18. Wang C., Hu F., Guo S., Mi D., Shen W., Zhang J., Qiao Y., Zhu T., Yang S. BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells. J. Cancer Res. Clin. Oncol. 2011, 137:985-995.
19. Takahashi M., Otsuka F., Miyoshi T., Otani H., Goto J., Yamashita M., Ogura T., Makino H., Doihara H. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J. Endocrinol. 2008, 199:445-455.
20. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
21. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
22. Lee Y.S., Nakahara K., Pham J.W., Kim K., He Z., Sontheimer E.J., Carthew R.W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004, 117:69-81.
23. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
24. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
25. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.
26. Corcoran C., Friel A.M., Duffy M.J., Crown J., O'Driscoll L. Intracellular and extracellular microRNAs in breast cancer. Clin. Chem. 2011, 57:18-32.
27. Kong W., He L., Richards E.J., Challa S., Xu C.X., Permuth-Wey J., Lancaster J.M., Coppola D., Sellers T.A., Djeu J.Y., Cheng J.Q. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 2013, (in press, Epub ahead of print).
28. Mertens-Talcott S.U., Chintharlapalli S., Li X., Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007, 67:11001-11011.
29. Scott G.K., Goga A., Bhaumik D., Berger C.E., Sullivan C.S., Benz C.C. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2007, 282:1479-1486.
30. Wu H., Zhu S., Mo Y.Y. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 2009, 19:439-448.
31. Rosa-Rosa J.M., Pita G., González-Neira A., Milne R.L., Fernandez V., Ruivenkamp C., van Asperen C.J., Devilee P., Benitez J. A 7Mb region within 11q13 may contain a high penetrance gene for breast cancer. Breast Cancer Res. Treat. 2009, 118:151-159.
32. Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., Tuschl T. New microRNAs from mouse and human. RNA 2003, 9:175-179.
33. Lim L.P., Glasner M.E., Yekta S., Burge C.B., Bartel D.P. Vertebrate microRNA genes. Science 2003, 299:1540.
34. Hino K., Tsuchiya K., Fukao T., Kiga K., Okamoto R., Kanai T., Watanabe M. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 2008, 14:1433-1442.
35. Kim T., Veronese A., Pichiorri F., Lee T.J., Jeon Y.J., Volinia S., Pineau P., Marchio A., Palatini J., Suh S.S., Alder H., Liu C.G., Dejean A., Croce C.M. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 2011, 208:875-883.
36. Senanayake U., Das S., Vesely P., Alzoughbi W., Fröhlich L.F., Chowdhury P., Leuschner I., Hoefler G., Guertl B. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012, 33:1014-1021.
37. Pichiorri F., Suh S.S., Rocci A., De Luca L., Taccioli C., Santhanam R., Zhou W., Benson D.M., Hofmainster C., Alder H., Garofalo M., Di Leva G., Volinia S., Lin H.J., Perrotti D., Kuehl M., Aqeilan R.I., Palumbo A., Croce C.M. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010, 18:367-381.
38. Chiang Y., Zhou X., Wang Z., Song Y., Liu Z., Zhao F., Zhu J., Xu H. Expression levels of microRNA-192 and -215 in gastric carcinoma. Pathol. Oncol. Res. 2012, 18:585-591.
39. Braun C.J., Zhang X., Savelyeva I., Wolff S., Moll U.M., Schepeler T., Ørntoft T.F., Andersen C.L., Dobbelstein M. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008, 68:10094-10104.
40. Song B., Wang Y., Kudo K., Gavin E.J., Xi Y., Ju J. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin. Cancer Res. 2008, 14:8080-8086.
41. Yan J.D., Yang S., Lü S.J., Lei R.Y., Zhu T.H. Expression of recombinant human BMP6 in CHO cells by fused to the signal peptide and propeptide of another homologue protein. Chin. J. Biotechnol. 2007, 23:413-417.
42. Mi D., Zhang M., Yan J.D., Zhang J., Wang X., Wang Q., Yang S., Zhu T.H. PTHrP inhibits BMP-6 expression through the PKA signaling pathway in breast cancer cells. J. Cancer Res. Clin. Oncol. 2011, 137:295-303.
43. Feng S., Cong S., Zhang X., Bao X., Wang W., Li H., Wang Z., Wang G., Xu J., Du B., Qu D., Xiong W., Yin M., Ren X., Wang F., He J., Zhang B. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 2011, 39:6669-6678.
44. Yamamoto Y., Oelgeschläger M. Regulation of bone morphogenetic proteins in early embryonic development. Naturwissenschaften 2004, 91:v519-v534.
45. Sharov A.A., Mardaryev A.N., Sharova T.Y., Grachtchouk M., Atoyan R., Byers H.R., Seykora J.T., Overbeek P., Dlugosz A., Botchkarev V.A. Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways. Am. J. Pathol. 2009, 175:1303-1314.
46. Shirai Y.T., Ehata S., Yashiro M., Yanagihara K., Hirakawa K., Miyazono K. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am. J. Pathol. 2011, 179:2920-2930.
47. Kim S.G., Park H.R., Min S.K., Choi J.Y., Koh S.H., Kim J.W., Lee H.W. Expression of bone morphogenic protein-4 is inversely related to prevalence of lymph node metastasis in gastric adenocarcinoma. Surg. Today 2011, 41:688-692.
48. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., Brant S.R., Chakravarti S., Kwon J.H. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135:1624-1635.
49. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
50. Chinnam M., Goodrich D.W. RB1, development, and cancer. Curr. Top. Dev. Biol. 2011, 94:129-169.
51. Sachdeva U.M., O'Brien J.M. Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J. Clin. Invest. 2012, 122:425-434.